Skip to main content
OpenTrials

Clinical trial condition

Rectal Neoplasms

Explore clinical trials studying Rectal Neoplasms. Study availability and eligibility vary by location and protocol.

180 public trials 48 recruiting studies
Refine in advanced search Browse all conditions

Rectal Neoplasms trial results

Active, not recruiting

Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer

NCT02314169

Conditions
Anal Canal Carcinoma, Anal Canal Squamous Cell Carcinoma, Anus Diseases, +14 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
View all 56 locations
View Trial Details
Active, not recruiting

Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study

NCT04166318

Conditions
Anal Basaloid Carcinoma, Anal Canal Carcinoma, Anal Canal Cloacogenic Carcinoma, +17 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 659 locations
View Trial Details
Active, not recruiting

EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients

NCT04444921

Conditions
Anal Basaloid Carcinoma, Anal Canal Carcinoma, Anal Canal Cloacogenic Carcinoma, +18 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 579 locations
View Trial Details
Active, not recruiting

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

NCT03233711

Conditions
Anal Basaloid Carcinoma, Anal Canal Carcinoma, Anal Canal Cloacogenic Carcinoma, +16 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 896 locations
View Trial Details
Active, not recruiting

Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group

NCT04230759

Conditions
Anal Cancer, Anal Cancer Stage II, Anal Cancer Stage III, +14 more
Locations
  • Univeritätsklinik für Strahlentherapie-Radioonkologie Graz, Austria
  • Institut für Radioonkologie und Strahlentherapie Darmstadt, Germany
  • Klinik und Poliklinik für Strahlentherapie und Radioonkologie Dresden, Germany
  • Klinik für Strahlenheilkunde, Universitätsklinikum Freiburg Freiburg im Breisgau, Freiburg, Germany
View all 25 locations
View Trial Details

Related conditions